FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine, namely new orodispersible forms of biologically active agents having an effect on general metabolic, excitatory and inhibitory nerve functions, intellectual mnestic cerebral functions. The biologically active agents contain glycine, vitamin B6 or its pharmaceutically acceptable salt and excipients which enable preparing the agent in the form of an orodispersible tablet.
EFFECT: composition may be used in various fields of therapy and prevention, particularly psychoneurology, and having an optimising effect on physiological and functional nerve activity in various borderline and pathological neural states; the agent is safe.
9 cl, 4 tbl, 4 ex
Authors
Dates
2012-09-20—Published
2011-06-02—Filed